Corcept Therapeutics Inc. is a pharmaceutical company engaged in the development of drugs for the treatment of serious metabolic and psychiatric disorders. The company’s main product modifies the action of cortisol, also known as the “stress hormone,” by blocking cortisol’s binding to one of two known receptors—the type 2 glucocorticoid receptor.
Get AI Stock Predictions Now
Download our app for real-time AI-powered stock predictions on iOS, Android, Windows and macOS
Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.